Clinical Trials Browser

Tuberous Sclerosis 2, Astrocytoma, Hereditary Sensory and Autonomic Neuropathies, Seizures, Tuberous Sclerosis, Lymphangioleiomyomatosis, Angiomyolipoma

NCT02116712 2016-11-30

The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)

Phase 1 Completed

9 enrolled

Lymphangioleiomyomatosis

NCT00005486 2016-02-18

Lymphangioleiomyomatosis (LAM) Registry

Completed

Lung Diseases, Lymphangioleiomyomatosis

NCT02009241 2015-12-11

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

Phase NA Completed

40 enrolled

Motor Activity, Lymphangioleiomyomatosis

NCT00989742 2015-12-02

Doxycycline In Lymphangioleiomyomatosis (LAM)

Phase 4 Completed

24 enrolled

Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00457964 2013-09-25

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

Phase 1/2 Completed

36 enrolled

Hereditary Sensory and Autonomic Neuropathies, Tuberous Sclerosis, Lymphangioleiomyomatosis

NCT00960895 2011-10-27

LAM-PH

Completed

20 enrolled

Hypertension, Pulmonary, Lymphangioleiomyomatosis

NCT00005906 2010-04-30

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Phase 2 Completed

4 enrolled 8 charts

Thoracic

Ascites, Chylous Ascites, Chylothorax, Lymphangiomyoma, Pleural Effusion, Lymphangioleiomyomatosis

NCT00001869 2008-03-04

Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)

Completed

400 enrolled

Pneumothorax, Tuberous Sclerosis, Lymphangioleiomyomatosis, Leiomyomatosis

NCT00457808 2007-04-09

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

Phase 2 Completed

25 enrolled

Tuberous Sclerosis, Lymphangioleiomyomatosis

Clinical Trials

Discovery of Sirolimus Sensitive Biomarkers in Blood

TRAIL

MILES

LAM-CAK

RESULT

LAM

Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma

COLA

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

Glutamine PET Imaging in LAM

Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases

A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis

SOS

LAMP-1

Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)

Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women

SAIL

The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients

EXIST-2

The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)

Lymphangioleiomyomatosis (LAM) Registry

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

Doxycycline In Lymphangioleiomyomatosis (LAM)

RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

LAM-PH

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)

Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM